LVM Capital Management Ltd. MI Trims Position in The Clorox Company (NYSE:CLX)

LVM Capital Management Ltd. MI lowered its holdings in The Clorox Company (NYSE:CLX) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,266 shares of the company’s stock after selling 180 shares during the period. LVM Capital Management Ltd. MI’s holdings in Clorox were worth $530,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the 3rd quarter valued at about $27,000. Continuum Advisory LLC boosted its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP boosted its holdings in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new stake in Clorox during the third quarter worth about $48,000. Finally, Friedenthal Financial purchased a new position in shares of Clorox in the 3rd quarter worth about $49,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of NYSE:CLX traded down $3.14 on Friday, reaching $157.49. 346,783 shares of the company’s stock were exchanged, compared to its average volume of 958,316. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The business’s 50-day moving average is $164.76 and its two-hundred day moving average is $155.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $19.49 billion, a price-to-earnings ratio of 54.87, a PEG ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 earnings per share. As a group, equities research analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.10%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.03%.

Analysts Set New Price Targets

A number of research firms recently issued reports on CLX. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $155.00 to $157.00 in a research note on Tuesday. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Barclays raised their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. Finally, TD Cowen raised Clorox from a “sell” rating to a “hold” rating and upped their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, Clorox currently has a consensus rating of “Hold” and an average target price of $157.46.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.